Atypical Presentation of Acquired Hypoganglionosis in a Patient Taking Clozapine
| Autor: | Anamaria Munteanu, Michael W. Fleischman, Lawrence Ku, Samuel W. French, Catherine Gisi, Viktor E. Eysselein |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
History
medicine.medical_specialty Constipation Polymers and Plastics Ileus medicine.drug_class Atypical antipsychotic Case Report RC799-869 Gastroenterology Industrial and Manufacturing Engineering 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Anticholinergic Business and International Management Clozapine Gastrointestinal dysmotility business.industry Diseases of the digestive system. Gastroenterology medicine.disease Hypoganglionosis Schizophrenia 030211 gastroenterology & hepatology medicine.symptom business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Case Reports in Gastrointestinal Medicine, Vol 2020 (2020) Case Reports in Gastrointestinal Medicine |
| ISSN: | 2090-6536 2090-6528 |
| Popis: | Acquired hypoganglionosis (HG) is a rare enteric gastrointestinal neuromuscular disorder previously associated with chronic inflammation that can lead to constipation, ileus, and even death. There is little known about the pathophysiology of acquired hypoganglionosis, and it is unclear if medications are related to the development of the disease. Clozapine is an atypical antipsychotic used to treat refractory schizophrenia that is well known for its side effects including agranulocytosis and gastrointestinal dysmotility. This is an unusual case of acquired hypoganglionosis in a patient with anticholinergic toxicity on clozapine therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text